The market could be headed for a big rotation. Read about three high-quality dividend stocks that can weather the disruption.

MoonLake Immunotherapeutics (MLTX) shares plunged after the company reported results from its Phase 3 trials for sonelokimab in hidradenitis suppurativa. The VELA-2 study missed its main goal, ...

Drug developers today have released a slew of announcements updating their programs – and the message is slow but steady ...

Jonathan Powell suppressed a major Whitehall investigation into Chinese spying after lobbying from the Treasury, The ...

Oil-Dri Corporation of America ( NYSE: ODC) Q4 2025 Earnings Call October 10, 2025 11:00 AM EDT ...

In a twist that has left many in shock, a major investigation into Chinese espionage was abruptly halted, raising eyebrows ...

What we like: Our top-pick memory-foam mattress topper is a good option for back and stomach sleepers. Offers medium-firm ...

Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in ...

India's electronics boom is quietly creating the next big winners. Three rising manufacturers are ramping up capacity, ...

In slow movements, each gunmetal gray robot grabs a towel by its corners, flattens it out, folds it twice, and deposits it ...

According to a CNBC article, investors are seeking gold as an investment amid rising economic and geopolitical uncertainties. In fact, most of the analysts believe that the U.S. stock market will ...

With no weight-loss drug and a focus on cancer, the FTSE 100 giant needs to perfectly manage its patent cliff-edge ...